UPS Healthcare, THREAD Partner on Decentralized Clinical Trial Platform

UPS Healthcare's clinical trial logistics unit, Marken, and THREAD, a decentralized clinical trial technology provider, partnered to bring together THREAD's digital platform and Marken's Home Healthcare and clinical trial logistics services to create a single seamless workflow for clients and patients. With the platform, sponsors and CROs no longer have to manage individual logistics and decentralized clinical trial platform vendors to set up a study. It also allows patients to coordinate all aspects of trial participation, from consent to sample analysis, with a single entity.

The modernized workflow and overall integration of Virtual Visit technology with a mobile provider network enables several in-person, coordinated activities to help improve the overall patient experience, including physical assessments, facilitation of sample and specimen collection, and streamlined UPS Healthcare logistics services. Additionally, the platform includes eConsent, eCOA, telehealth Virtual Visits, patient engagement and eSource, along with other features, to make digital recruitment easier. Integrating these features within one common workflow aims to simplify the clinical trial study visit to a participant's home, easing the burden for patients and providers. 

"UPS Healthcare and our Marken unit have an ongoing commitment to investing in the latest technologies and digital innovations to improve the overall patient experience," said Wes Wheeler, UPS Healthcare president. "This partnership with THREAD is the first step in redefining the clinical trial experience across the industry, making the delivery of critical treatments more efficient and expediting care for patients."

"Marken's combination of home health and clinical trial logistics services are industry-leading," said John Reites, CEO, THREAD. "Partnering with UPS, we are excited to bring together THREAD and Marken's complementary capabilities to provide a uniquely comprehensive, flexible and inclusive data collection model for our decentralized clinical trial customers."